Gadolinium Warnings from the FDA
The FDA has released three warnings about gadolinium-containing contrast agents after the dyes were linked to the development of nephrogenic systemic fibrosis in kidney patients. Click the links below to learn more about these FDA warnings.
Gadolinium Contrast Dye FDA Gadolinium Warnings
A guide to the three FDA gadolinium warnings.
If you might have a Gadolinium Contrast Dye case, we can help. Contact our Gadolinium Contrast Dye Lawyers.
This is the first time in my life that I needed a lawyer. I wasn't sure where to turn to find a good attorney, but Lawyer Central reviewed my case quickly and promptly found an experienced lawyer to represent me.
- Mary Alice M. -Milwaukee, WI
-
Nephrogenic Systemic Fibrosis
A guide to the symptoms, causes and treatments for Nephrogenic Systemic Fibrosis (NSF).
-
Gadolinium Dye Agents
A guide to the five brands of gadolinium contrast dyes.
-
FDA Gadolinium Warnings
A guide to the three FDA gadolinium warnings.
-
Gadolinium Explained
An overview of gadolinium, including sides effects and gadolinium FAQs.
-
MRI and MRA Risks
A guide to MRIs and MRAs including risks, questions for your doctor and preparing for an MRI.
